Evidence map›Paper›PMID 24560607›Full record

ArticleChemistry & biology2014

Structure-guided design of fluorescent S-adenosylmethionine analogs for a high-throughput screen to target SAM-I riboswitch RNAs.

Scott F Hickey, Ming C Hammond

Abstract read
In one paragraph

Article in Chemistry & biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. A cooperative effect of ligands, MgThe Journal of biological chemistry · 2026
    Article
  2. Article
  3. Article
  4. A Riboswitch-Driven Era of New Antibacterials.Antibiotics (Basel, Switzerland) · 2022
    Review
  5. Article
  6. Analogs ofMolecular biology · 2022
    Article
  7. Riboswitches as Drug Targets for Antibiotics.Antibiotics (Basel, Switzerland) · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Recent advances and future trends of riboswitches: attractive regulatory tools.World journal of microbiology & biotechnology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Synthesis and characterization ofJournal of sulphur chemistry · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott F HickeyDepartment of Chemistry, University of California, Berkeley, CA 94720, USA; Synthetic Biology Institute, University of California, Berkeley, Berkely, CA 94720, USA.
Ming C HammondDepartment of Chemistry, University of California, Berkeley, CA 94720, USA; Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA; Synthetic Biology Institute, University of California, Berkeley, Berkely, CA 94720, USA. Electronic address: mingch@berkeley.edu.

Funding

Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
A Chemical Biology Approach to Tagging RNAs in Live CellsDP2OD008677 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI HAMMOND, MING CHEN · 2011 to 2011
$2.3M
NIGMS NIH HHS T32 GM066698NIH HHS 1DP2OD008677NIH HHS DP2 OD008677
6 · The paper itself

Abstract

Many classes of S-adenosylmethionine (SAM)-binding RNAs and proteins are of interest as potential drug targets in diverse therapeutic areas, from infectious diseases to cancer. In the former case, the SAM-I riboswitch is an attractive target because this structured RNA element is found only in bacterial mRNAs and regulates multiple genes in several human pathogens. Here, we describe the synthesis of stable and fluorescent analogs of SAM in which the fluorophore is introduced through a functionalizable linker to the ribose. A Cy5-labeled SAM analog was shown to bind several SAM-I riboswitches via in-line probing and fluorescence polarization assays, including one from Staphylococcus aureus that controls the expression of SAM synthetase in this organism. A fluorescent ligand displacement assay was developed and validated for high-throughput screening of compounds to target the SAM-I riboswitch class.

Indexed as

Drug DesignRiboswitchBacterial ProteinsBinding SitesCarbocyaninesCrystallography, X-RayFluorescence PolarizationFluorescent DyesHigh-Throughput Screening AssaysKineticsMethionine AdenosyltransferaseMolecular Dynamics SimulationNucleic Acid ConformationRNA, BacterialRNA, MessengerS-AdenosylmethionineBacterial ProteinsCarbocyaninescyanine dye 5Fluorescent DyesMethionine AdenosyltransferaseRiboswitchRNA, BacterialRNA, MessengerS-Adenosylmethionine

Identifiers

PMID24560607
PMCPMC4074398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.